AK

Arvind Kejriwal

Active Director Director DIN 06488118
DIN 06488118 First appointment May 2013 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2013
Shareholding value •••• Premium profile

About Arvind Kejriwal

Data last updated:

Arvind Kejriwal is a Director at Elyon Pharmaceuticals Private Limited (since 2013). The company operates in Chemicals. Elyon Pharmaceuticals Private Limited reported revenue of ₹1.24 Cr (FY 2025).

DIN 06488118
Primary Designation Director
Industry Chemicals
First Appointment 08 May 2013
Oldest Company Age 13 yrs
Largest company Elyon Pharmaceuticals Private Limited · ₹1.24 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 May 20132013₹1.24 Cr (FY 2025)Active

Board colleagues of Arvind Kejriwal

Directorship timeline

Open interactive timeline →
Elyon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arvind Kejriwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arvind Kejriwal

Arvind Kejriwal currently holds 1 directorship: Elyon Pharmaceuticals Private Limited (Director, since 08 May 2013, revenue ₹1.24 Cr (FY 2025)).

Arvind Kejriwal was first appointed on 08 May 2013 as Director at Elyon Pharmaceuticals Private Limited.

The current boards of Arvind Kejriwal's companies include Aditya Kejriwal (Elyon Pharmaceuticals Private Limited), Bijay Kumar Kejriwal (Elyon Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available